Review of the current and post-Brexit UK legal framework on the regulation of genetic technologies by Firmansyah, Adiba
   





  Review of the current and post-Brexit UK legal
framework on the regulation of genetic technologies
Firmansyah Adiba  
https://doi.org/10.12681/bioeth.28152
 
  Copyright © 2021 Adiba Firmansyah 
   
  
   
To cite this article:
Firmansyah, A. (2021). Review of the current and post-Brexit UK legal framework on the regulation of genetic
technologies. Bioethica, 7(2), 51-68. doi:https://doi.org/10.12681/bioeth.28152
http://epublishing.ekt.gr | e-Publisher: EKT | Downloaded at 10/12/2021 10:06:40 |
Review                                                                                                                                                                         Ανασκόπηση 
 
51 








Review of the current and post-Brexit UK legal framework on the regulation 













 The launch of a nationwide consultation in January 2021 by the UK Department for the 
Environment, Food and Rural Affairs (Defra) on the regulation of genetic technologies has been used as 
an opportunity by the UK Government to gauge public and scientific opinion on the applications of gene 
editing in agriculture and aquaculture. In particular, the consultation sought to consider the controversial 
question of whether gene editing (GE) should be subject to the same regulations as genetically modified 
organisms (GMOs). The distinction between GE and GMO products, as well as between the legal 
regulations governing them, are highly important: currently, the UK still follows the EU’s restrictive 
approach, whereby gene editing is regulated in the same way as GMOs. However, in light of the UK’s 
departure from the EU, the UK government seems willing to reconsider this approach and adopt a new 
regulatory framework characterised by less stringent controls. Accordingly, this review paper examines 
the current legal framework on gene editing and GMOs in the UK and EU, as well as in other relevant 
jurisdictions, before then examining the Defra consultation in light of the mixed responses to it from both 
the scientific community and the general public. The paper concludes with a number of considerations 
that should inform any proposed post-Brexit reform of the framework that allows for the correct balance 
to be struck between scientific development, food security, human health, and the environment. 
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Ανασκόπηση του ισχύοντος και του μετά Βrexit νομικού πλαισίου του 









 Η έναρξη μιας εθνικής διαβούλευσης τον Ιανουάριο του 2021 από το Υπουργείο Περιβάλλοντος, 
Τροφίμων και Αγροτικών Υποθέσεων του Ηνωμένου Βασιλείου (Defra), σχετικά με τη ρύθμιση των 
γενετικών τεχνολογιών, έδωσε στην κυβέρνηση του Ηνωμένου Βασιλείου την ευκαιρία για τη μέτρηση 
της κοινής και επιστημονικής γνώμης σχετικά με τις εφαρμογές της γονιδιακής επεξεργασίας στη 
γεωργία και την υδατοκαλλιέργεια. Ειδικότερα, η διαβούλευση επεδίωξε να εξετάσει το αμφιλεγόμενο 
ζήτημα του κατά πόσον η γονιδιακή επεξεργασία θα πρέπει να υπόκειται στους ίδιους κανονισμούς με 
τους γενετικά τροποποιημένους οργανισμούς (ΓΤΟ). Η διάκριση μεταξύ των προϊόντων γονιδιακής 
επεξεργασίας και των ΓΤΟ, καθώς και μεταξύ των νομικών ρυθμίσεων που τα διέπουν, είναι εξαιρετικά 
σημαντική: επί του παρόντος, το Ηνωμένο Βασίλειο συνεχίζει να ακολουθεί την περιοριστική 
προσέγγιση της ΕΕ, σύμφωνα με την οποία η γονιδιακή επεξεργασία ρυθμίζεται με τον ίδιο τρόπο όπως 
και οι ΓΤΟ. Ωστόσο, υπό το πρίσμα της αποχώρησης του Ηνωμένου Βασιλείου από την ΕΕ, η βρετανική 
κυβέρνηση φαίνεται πρόθυμη να επανεξετάσει αυτή την προσέγγιση και να υιοθετήσει ένα νέο 
ρυθμιστικό πλαίσιο που θα χαρακτηρίζεται από λιγότερο αυστηρούς ελέγχους. Κατά συνέπεια, η 
παρούσα ανασκόπηση εξετάζει το ισχύον νομικό πλαίσιο σχετικά με τη γονιδιακή επεξεργασία και τους 
ΓΤΟ στο Ηνωμένο Βασίλειο και την ΕΕ, καθώς και σε άλλες χώρες, προτού εξετάσει στη συνέχεια τη 
διαβούλευση της Defra, υπό το πρίσμα των ανάμεικτων αντιδράσεων σε αυτήν, τόσο από την 
επιστημονική κοινότητα όσο και από το ευρύ κοινό. Η ανασκόπηση καταλήγει σε μια σειρά από 
εκτιμήσεις που θα πρέπει να τροφοδοτήσουν κάθε προτεινόμενη μεταρρύθμιση του μετά Brexit πλαισίου, 
που θα συμβάλλει στην επίτευξη της σωστής ισορροπίας μεταξύ της επιστημονικής εξέλιξης, της 
ασφάλειας των τροφίμων, της ανθρώπινης υγείας και του περιβάλλοντος. 
 
Λέξεις κλειδιά: βιοηθική, ΓΤΟ, γονιδιακή επεξεργασία, γεωργία, Ηνωμένο Βασίλειο. 
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A. Introduction 
In January 2021, the UK Department for 
the Environment, Food and Rural Affairs (Defra) 
launched a consultation on the regulation of 
genetic technologies, and in particular, on the 
applications of gene editing in agriculture and 
aquaculture.1 To that end, the Defra consultation 
will consider the controversial question of 
whether gene editing (GE) should be subject to 
the same regulations as genetically modified 
organisms (GMOs).2 In this respect, it is 
important to note that gene editing is different 
from genetic modification, which involves DNA 
from one species being introduced to another.3 In 
contrast, gene edited organisms do not contain 
DNA from different species, and instead involve 
the use of technologies, such as CRISPR (e.g., 
clustered regularly interspaced short palindromic 
repeats/Cas9) that produce quicker and more 
precise changes to organisms that would have 
occurred naturally - but far more slowly - over 
time using traditional breeding methods.4 
At the moment the UK still follows the 
European Union’s approach, whereby gene 
editing is regulated in the same way as GMOs.5 
However, in light of the UK leaving the EU, the 
UK Government seems willing to adopt a new 





1 UK Department for the Environment, Food and 
Rural Affairs. The regulation of genetic technologies. 
2021. https://consult.defra.gov.uk/agri-food-chain-
directorate/the-regulation-of-genetic-technologies/ 
accessed 29 March 2021. 
2 Ibidem. 
3 UK Department for the Environment, Food and 




g%20Explainer.pdf accessed 29 March 2021. 
4 Ibidem. 
5 Defra, The regulation of genetic technologies, 
op.cit. 
regulatory framework on gene editing: one that 
is subject to less strict controls and that has the 
potential, as the Government sees it, to ‘breed 
crops that perform better, reduc[e]costs to 
farmers and impacts on the environment and 
help us all adapt to the challenges of climate 
change’.6 Yet others have argued that the 
possible harm to human health from scientific 
intervention at the genetic level and from 
reduced safeguards is too high a risk to accept.7 
This review paper will first set out the current 
legal framework on gene editing and GMOs in 
the UK and EU, as well as in other relevant 
jurisdictions, before then examining the Defra 
consultation in light of the responses to it that 
have been both positive and critical. The paper 
concludes with a number of considerations that 
should inform any proposed reform of the 
framework post-Brexit and that allows for the 
correct balance to be struck between scientific 
development, food security, human health, and 
the environment. 
 
B. The legal framework on gene edited and 
genetically modified crops: a global overview 
Over the last two years alone, 26 countries 
grew approximately 190 million hectares of GM 
crops.8 Of these 26 countries, 21 are developing 
countries and five are industrial countries.9 





6 Sandercock H. Defra launches consultation on crop 
gene editing plans. The Grocer 2021. 
https://www.thegrocer.co.uk/fruit-and-veg/defra-
launches-consultation-on-crop-gene-editing-
plans/651858.article accessed 29 March 2021. 
7 Marshall C. Consultation launched over gene edited 
food in England. BBC 2021. 
https://www.bbc.com/news/science-environment-
55576187  accessed 29 March 2021. 
8 Turnbull C, et al. Global Regulation of Genetically 
Modified Crops Amid the Gene Edited Crop Boom – 
A Review. Frontiers in Plant Science 2021: 12. 
9 Ibidem. 
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Industrial countries include the United States, 
Australia, and Canada, growing around 46% of 
total GM crops.10 The developing countries 
growing 54% of the total include India, Brazil 
and Argentina.11 Against this background, it is 
important to examine the regulatory framework 
of these countries that enables cultivation of GM 
crops on such a large scale. 
Governments around the world will 
generally seek to create a regulatory framework 
that provides the necessary safeguards for their 
citizens and for the environment.12 In a similar 
vein, the laws applying to agriculture and 
aquaculture destined for consumption will seek 
to protect these human and environmental 
interests. Yet the way this is implemented will 
differ between countries and regions. Broadly 
speaking, GM regulations are usually categorised 
into process- or product-oriented regulations.13 
Process-oriented regulations categorise GM 
technologies as a novel technique compared to 
traditional breeding methods, thereby triggering 
specific legislation to be applied.14 These types 
of GM regulations ensure that in the event 
genetic technologies and engineering are used, 
there are some checks on whether any errors 
have been introduced during the process of 
engineering before the crop or animal is farmed 
and/or eaten.15 Accordingly, process-oriented 





10 International Service for the Acquisition of Agri-
biotech Applications (ISAAA). GM Approval 
Database 
http://www.isaaa.org/gmapprovaldatabase/default.asp 
accessed 29 March 2021. 
11 Ibidem. 
12 Turnbull, op cit.: 3. 
13Sprink T, et al. Regulatory hurdles for genome 
editing: process-vs. product-based approaches in 
different regulatory contexts. Plant Cell Reports 
2016, 35: 7. 
14 Ibidem. 
15 Sam C. New developments in modern 
biotechnology: A survey and analysis of the 
regulations emphasises that how an organism is 
produced is relevant.16 Proponents of this 
approach highlight that direct intervention at the 
genetic level differs from traditional breeding 
methods and that this may lead to unexpected 
errors across the genome and that may pose a 
threat to humans or the environment.17 
Product-oriented regulations, on the other 
hand, emphasise the novel characteristics of the 
product compared to those produced by 
traditional breeding methods.18 A move to 
product-based regulations, therefore, means that 
regulators will no longer be required to consider 
how a plant or animal was created.19 This lack of 
oversight has been criticised for the potential risk 
stemming from unexpected results, such as new 
allergens or toxins, that may go unnoticed, if 
there are no checks on the processes used by 
scientists and genetic engineers.20 Consequently, 
it has been argued that consumers may then be 
forced to simply take their word for it that these 
scientists have only made the DNA changes 
planned and declared.21 At this point, Canada is 
the only country in the world that has based their 





regulatory status of plants produced through New 
Breeding techniques. 
https://lib.ugent.be/fulltxt/RUG01/002/213/647/RUG
01-002213647_2015_0001_AC.pdf accessed 29 
March 2021. 
16 GM Freeze. GM Freeze advice on responding to 
the UK consultation on the deregulation of gene 
editing. January 2021. https://www.gmfreeze.org/wp-
content/uploads/2021/01/GMF-Gene-Editing-
Consultation-1-2.pdf accessed 29 March 2021. 
17 Idem: 5. 
18 McHughen A. A critical assessment of regulatory 
triggers for products of biotechnology: product vs. 
process. GM Crops Food 2016: 7. 
19 GM Freeze, op cit.: 16. 
20 Ibidem. 
21 Ibidem. 
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entire GM regulatory framework on the product-
oriented approach.22 
Discussions on the regulation of gene 
edited organisms have, therefore, mainly 
centered on which of the two approaches is 
best.23 Research by Eckerstorfer concluded that 
both systems have their advantages and 
disadvantages and neither system can be said to 
be better than the other.24 While there is no broad 
consensus yet, biotechnology scientists globally 
seem to be in favour of the product-based 
approach, as it has been deemed to be a more 
‘scientifically-friendly' approach.25 Indeed, 
McHughen has noted that scientific assessments 
should form the basis of effective risk 
management, and that regulations rely heavily on 
risk management to protect human health and the 
environment.26 However, as Turnbull 
emphasises, even as science must shape 
regulatory frameworks, this cannot and does not 
occur in isolation.27 
 
I. The restrictive approach to regulating 
biotech 
As the point of departure in discussing the 
potential reforms to the UK regulatory 
framework on gene edited organisms, it is 





22 Ellens K, et al. Canadian regulatory aspects of gene 
editing technologies. Transgenic Research 2019, 28: 
2. 
23 Sprink, op cit.: 1493-1506. 
24 Eckerstorfer MF, Engelhard M, Heissenberger A, 
Simon S, Teichmann H. Plants developed by new 
genetic modification techniques - comparison of 
existing regulatory frameworks in the EU and Non-
EU countries. Frontiers of Bioengineering and 
Biotechnology 2018, 7: 26. 
25 Turnbull, op cit.: 3. 
26 McHughen A. A critical assessment of regulatory 
triggers for products of biotechnology: product vs. 
process. GM Crops Food 2016: 7. 
27 Turnbull, op cit.: 3. 
necessary to start with the approach of the EU, 
which the UK currently retains. 
1. European Union 
In the EU, Regulation (EC) No 1829/2003 
on genetically modified food and feed binds all 
27 Member States and covers GM food and feed 
produced ‘from’ a GMO, including food and 
feed products and their imports.28 Prioritising a 
high level of protection to human, animal and 
environmental health,29 the Regulation governs 
the authorisation procedures related to GM 
organisms and is applied in conjunction with 
Regulation 1830/2003 on the tracing and 
labelling of GM products.30 However, in relation 
to the cultivation of GM crops, Member States 
may choose their own approach under Directive 
2001/18/EC on the deliberate release into the 
environment of genetically modified organisms 
(referred to as the ‘Cultivation Directive’). This 
Directive provides for the cultivation of GM 
crops only once there has been a rigorous 
assessment of potential negative impacts on 
human health and the environment.31 
Under the Cultivation Directive, Member 
States are allowed to ‘provisionally restrict or 
prohibit the use and/or sale of that GMO as or in 
a product on its territory’.32 Once the European 
Food Safety Authority (EFSA) approves a 
particular crop for cultivation, Article 23 of the 
Directive allows Member States to restrict or 
prohibit that GM crop from cultivation in their 
territory. Since the inclusion of this clause into 
the Directive, a number of EU Member States 





28 Paragraph 16 of the Preamble to the Regulation 
(EC) No 1829/2003. 
29 Article 1 of Regulation 1829/2003. 
30 Regulation (EC) No 1830/2003 on the traceability 
and labeling of genetically modified organisms 
(GMOs) and the traceability of food and feed 
products produced from GMOs. 
31 Article 2(8) of Directive 2001/18/EC. 
32 Article 23(1) of Directive 2001/18/EC. 
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have imposed a de facto ban on the cultivation of 
GM crops, including France and Germany.33 
The EU’s approach to defining a 
‘genetically modified organism’ is often pointed 
to as a prime example of a process-triggered 
regulatory framework.34 Article 2(2) of the 
Cultivation Directive states that an organism is 
genetically modified if the alteration of genetic 
material is carried out in a way that is not natural 
mating and/or recombination. Notably, this 
definition is consistent with the concepts and 
terminology of international treaties such as the 
Cartagena Protocol on Biosafety to the 
Convention on Biological Diversity.35 In its 
landmark ruling in 2018, the European Court of 
Justice (ECJ) interpreted this provision to mean 
that organisms altered through site-directed 
metagenesis (the formation of mutations in DNA 
molecules), such as through CRISPR/Cas9, were 
to be included in the definition of a GMO.36 The 
implications of this judgment are that the size or 
type of modification to the genetic material 
becomes irrelevant. As Wasmer notes, if there is 





33 Lombardo L, Grando MS. Genetically modified 
plants for nutritionally improved food: a promise 
kept?. Food Reviews International 2020: 36. 
34 Marchant GE, Stevens YA. A new window of 
opportunity to reject process-based biotechnology 
regulation. GM Crops Food 2015: 6. 
35 Bendiek J, Buhk H. Risk Assessment and 
Economic Applications – the Cartagena Protocol on 
Biosafety: GMO Approval and Import on a World-
Wide Scale. In: Kempken F, Jung C (eds). Genetic 
Modification of Plants. Springer, 2010: 631. 
36 Judgment of the Court (Grand Chamber), 25 July 
2018 in Case C-528/16 Confédération paysanne and 
Others v Premier ministre and Ministre de 





e=req&dir= accessed 29 March 2021. 
mutagenesis, whether random or controlled, big 
or small, the organism will be legally categorised 
as a GMO.37 Accordingly, the ECJ clarified that 
this rule should be the starting point for the 
determination of what constitutes a GMO.38 
However, it also highlighted that there are 
exceptions to this strict approach in the 
accompanying exceptions to the Cultivation 
Directive, and that these are only included based 
on their long safety record.39 
Indeed, EU law on GM food covers most 
modified plant products, aside from those 
created by the exempted techniques.40 Such 
techniques include those involving mutation 
breeding based on techniques used before the 
Directive came into force in 2001, but not any of 
the newer forms of mutagenesis.41 This 
inconsistency means that, as a result, the ECJ’s 
decision has been heavily criticised as being 
arbitrary and accusations that the regulations are 
no longer fit for purpose.42 However, the ECJ 
decision did prompt the Council of the European 
Union to request a study on the status of ‘new 





37 Wasmer M. Roads forward for European GMO 
policy-uncertainties in wake of ECJ judgment have to 
be mitigated by regulatory reform. Frontiers of 
Bioengineering and Biotechnology 2019, 7: 132 
38 ECJ, 2018, op cit.: paras. 44–46. 
39 Exempted techniqes are listed in Annex I A Part 2 
and Annex I B of Directive 2001/18/EC. 
40 Eriksson D, Custers R, Edvardsson Björnberg K, 
Hansson SO, Purnhagen K, Qaim M. Options to 
reform the European Union legislation on GMOs: 
scope and definitions. Trends in Biotechnology 2020, 
38: 231–234. 
41 Wanner B, Monconduit H, Mertens A, and 
Thomaier J. CJEU renders decision on the 
interpretation of the GMO Directive. Journal of 
Intellectual Property Law and Practice 2019: 14. 
42 Smyth S. Canadian regulatory perspectives on 
genome engineered crops’ GM Crops & Food 2017, 
8: 1. 
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genomic techniques’.43 This seems to be a 
positive step, as the concrete evidence collected 
will underpin and inform any potential reform of 
EU law. 
 
2. United Kingdom 
As the UK Government highlighted in its 
announcement of the Defra consultation, EU law 
controlling the use of GMOs was retained by the 
UK at the end of the Brexit transition period 
(after 31 December 2020).44 This retained 
legislation mandates all gene edited organisms to 
be classified as GMOs regardless of whether 
they could be produced by traditional breeding 
methods, in line with the 2018 ECJ ruling.45 
In terms of the governing body responsible for 
these issues, the Department for Environment, 
Food and Rural Affairs (Defra) is the lead 
government department in England for 
overseeing the use of GMOs and for protecting 
the environment more generally.46 As for the 
legislation in England and Wales that governs 
GMOs and that implements EU law, the 
Environmental Protection Act 1990 is the 





43 Council Decision (EU) 2019/1904 of 8 November 
2019 requesting the Commission to submit a study in 
light of the Court of Justice’s judgment in Case C-
528/16 regarding the status of novel genomic 
techniques under Union law, and a proposal, if 
appropriate in view of the outcomes of the study.  
44 Defra. The regulation of genetic technologies: A 
public consultation on the regulation of genetic 





NAL.pdf accessed 29 March 2021. 
45 Idem: 5.  
46 Defra. About us. 
https://www.gov.uk/government/organisations/depart
ment-for-environment-food-rural-affairs/about 
accessed 29 March 2021. 
primary piece of legislation addressing GMOs.47 
It empowers the Secretary of State with the 
authority and responsibility to control the 
deliberate release of GMOs in England.48 
Moreover, in line with the EU definition of 
GMOs, Part IV, section 6 of the Environmental 
Protection Act 1990 defines an organism as 
genetically modified if: 
(4) ... any of the genes or other genetic 
material in the organism—  
[F4 (a) have been artificially modified, or]  
(b) are inherited or otherwise derived, 
through any number of replications, from 
genes or other genetic material (from any 
source) which were so modified.  
[F5 (4A) Genes or other genetic material in 
an organism are “artificially modified” for 
the purposes of subsection (4) above if they 
are altered otherwise than by a process which 
occurs naturally in mating or natural 
recombination.49 
Then, in accordance with the main EU 
directive regulating the release of GMOs across 
Member States in Directive 2001/18, the UK 
implemented this legislation in the Genetically 
Modified (Deliberate Release) Regulations 
2002.50 Additionally, there is an extensive set of 
regulations on the use and labeling of GMOs in 
food, primarily based upon EU law. The EU 
Regulations governing the use of GMOs in food 
products across Member States in Regulations 
1829/2003 and 1830/2003 are implemented in 
England by the Genetically Modified Food 
(England) Regulations 2004, the Genetically 
Modified Animal Feed (England) Regulations, 
and the Genetically Modified Organisms 





47 Environmental Protection Act 1990.  
48 Ibidem. 
49 Environmental Protection Act, Part IV, section 6.  
50 Genetically Modified (Deliberate Release) 
Regulations 2002.  
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(Traceability and Labelling) (England) 
Regulation.   
Post-Brexit, however, the regulatory 
framework on GMOs seems set to change and 
has been questioned as to its suitability in the 
context of gene edited organisms. Defra has 
already stated that it is of the view that gene 
edited organisms should not be regulated as 
GMOs if they could have been produced by 
traditional breeding methods.51 Seeing Brexit as 
an opportunity to consult on the wider 
implications of this issue, Defra’s consultation is 
therefore an invitation to relevant stakeholders to 
share their views on the path forward.52 
 
II. The less restrictive approach to regulat-
ing biotech 
This path forward could take the form of a 
less restrictive approach to the regulation of gene 
edited organisms. In this respect, it is useful to 
consider jurisdictions in which such an approach 
is implemented.  
 
1. United States 
The US leads the world in developing and 
commercialising GM crops, with a 30% global 
market share in agricultural biotechnology.53 
However, unlike most other countries, the US 
has no federal law that regulates GMOs.54 
Instead, a mechanism is in place whereby newly 
developed GM products are directed to 





51 Defra, The regulation of genetic technologies, op 
cit. 
52 Ibidem.  
53 Report Linker. Global Agricultural Biotechnology 
Industry: Global Agricultural Biotechnology Market 
to Reach US$66.2 Billion by the Year 2027. July 
2020. https://www.prnewswire.com/news-
releases/globalagricultural-biotechnology-industry-
301092902.html accessed 29 March 2021. 
54 Yang T, Chen B. Governing GMOs in the USA: 
science, law and public health. Journal of the Science 
of Food and Agriculture 2016, 96: 6. 
regulatory bodies under the Coordinated 
Framework for Regulation of Biotechnology.55 
As a result, GM products are assessed within the 
same framework used for conventional products 
and under the same health, safety and 
environmental legislation.56 This means that the 
assessment of new GM crops can involve many 
different laws and agencies, including the Food 
and Drug Administration (FDA), the 
Environmental Protection Agency (EPA) and the 
US Department of Agriculture (USDA).57 In 
particular, the USDA’s Animal and Plant Health 
Inspection Service (APHIS) is empowered to 
ensure that GM plants will not be a pest risk to 
other plants.58 APHIS then designates these 
plants as being of either regulated or non-
regulated status – the latter status ensuring that 
the plant may be cultivated, imported and 
transported without regulatory oversight by 
APHIS.59 If the GM plant is intended for 
consumption, the FDA will then take over to 
assess the safety of the GM food product.60 





55 Kingsbury D. Regulation of biotechnology in the 
United States: One and a half years of using the 
‘coordinated framework’. Trends in ecology & 
evolution 1988. 3: 4. 
56 Matthews K. Continuing Evolution of the 
Coordinated Framework: Implications for 
Agricultural Biotechnology. In American Chemical 
Society. Navigating Legal Challenges in the 
Agrochemical Industry. ACS Publications, 2020. 
57 Paoletti C, et al. GMO risk assessment around the 
world: some examples. Trends in Food Science & 
Technology 2008: 19. 
58 McHughen A and Smyth S. US regulatory system 
for genetically modified [genetically modified 
organism (GMO), rDNA or transgenic] crop 
cultivars. Plant Biotechnology Journal 2006, 6: 1. 
59 Nelson G (ed). Genetically Modified Organisms in 
Agriculture. Elsevier, 2001: 97-116. 
60 Dudek C. 12 GMO Food Regulatory Frameworks 
in the US and the EU. In Henderson K (ed). The New 
and Changing Transatlanticism: Politics and Policy 
Perspectives. Routledge, 2015: 214. 
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There are currently 128 GM plant varieties that 
have non-regulated status because they do not 
contain foreign DNA originating from ‘plant 
pests’, such as bacteria, viruses and insects.61 
Similarly, when it comes to CRISPR/Cas9-
modified food crops, a common button 
mushroom was found in 2016 to resist browning 
and spoilage, and accordingly, was granted non-
regulated status.62 From that point onwards, 
several other gene edited food products have 
entered the market: such as Calyno, a high oleic 
soybean oil and SU (sulfonylurea) Canola, a 
herbicide tolerant canola.63 
It seems unlikely that the UK would adopt 
the US approach of handing over regulatory 
oversight to agencies and the general patchwork 
of legislation on health, safety and the 
environment. Yet the US approach of 
designating some GM plants as being of non-
regulated status may encourage greater scientific 
developments and in conjunction with the safety 
checks on plants intended for consumption, may 
be a viable option. However, the UK should be 
aware that the US approach remains open for 
criticism because APHIS only checks GM plants 
for their potential as pest risks, and not for other 
kinds of risks, such as risks that do not stem 
from plant pests or risks that may harm humans 
and not just the environment. As such, it is 
advisable that the Defra consultation take into 









status accessed 29 March 2021. 
62 Waltz E. Gene-edited CRISPR mushroom escapes 
US regulation. Nature News 2016, 532: 7599. 





accessed 29 March 2021. 
account a wider conception of risks than is 
currently the case in the US via APHIS. 
 
2. Canada 
As one of the top five largest biotech crop 
cultivators, Canada contributes 6.6% of the total 
worldwide biotech crop area in 2018.64 Notably, 
Canada follows the product-oriented approach in 
their regulatory framework, which has been held 
up by some as fostering greater innovation in 
agricultural biotechnology.65 What is unique 
about Canada’s legislation in comparison to 
other product-based regulatory frameworks is the 
emphasis on the mere presence of a novel 
characteristic, and not the way it was modified.66 
In this way, the same risk assessment mechanism 
carried out by the Canadian Food Inspection 
Agency is applied to all novel plant products – 
regardless of whether the novel characteristic 
was introduced via traditional breeding methods, 
traditional mutagenesis, or directed 
mutagenesis.67 
Against this background, Smyth has 
argued that Canada’s regulatory framework has 
allowed it to take a strictly science-based 
assessment of risks related to novel plants, 
focusing in particular on the potential allergens, 
toxicity, and other unexpected impacts the plant 





64 ISAAA. Global Status of Commercialized 




es%20in%202017 accessed 29 March 2021. 
65 Atanassova A, Keiper F. Plant breeding 
innovation: a global regulatory perspective. Cereal 
Chemistry 2018: 95. 
66 Smyth S, op cit. 
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may contain.68 The trigger for the regulations is 
when a plant exhibits a particular characteristic 
that is at least 20-30% lower or higher compared 
to traditional varieties.69 At this stage, the plant 
is designated as a plant with novel traits (PNT) – 
and not a ‘GMO’.70 Commercialisation may only 
occur with the approval of the Canadian Food 
Inspection Agency (CFIA).71 Moreover, plant 
products intended as food must pass an 
additional assessment by Health Canada and an 
assessment of feed will be undertaken by the 
Animal Feed Division of the CFIA.72 
For the UK to adopt a Canadian approach 
would require a complete overhaul of the current 
regulations from the process-based approach to a 
product-based approach. Yet it is notable that the 
Canadian mechanism for assessing the safety of 
novel plant products does not simply ‘take the 
scientists’ word for it’ that the product will have 
no harmful impacts. Accordingly, the 
accusations of UK anti-GMO NGOs that this 
extreme lowering of standards and oversight 
need not be true so long as the risk assessment of 
novel plants does indeed cover the allergens, 
toxicity and the other risks that may develop as a 
result of gene edited or gene modified food.73 





68 Smyth, op cit.  
69 Smyth S. Regulation of genome editing in plant 
biotechnology: Canada. In: Dederer H, Hamburger H 
(eds). Regulation of Genome Editing in Plant 
Biotechnology. Springer, 2019:111-135. 
70 CFIA, op cit. 
71 Turnbull, op cit.: 6. 




29 March 2021. 
73 Jiang L. Commercialization of the gene-edited crop 
and morality: challenges from the liberal patent law 
and the strict GMO law in the EU. New Genetics and 
Society 2020, 39: 2. 
C. Impact of Defra consultation on future 
UK law 
 
I. First part of Defra consultation 
The two-part Defra consultation was 
carried out under promises made under the 
Agricultural Bill in 2020.74 In this respect, as 
Peter Mills from the Nuffield Council on 
Bioethics notes, ‘the indecent haste after the end 
of the Brexit transitional period, hiving off a 
class of applications as a potential ‘quick win’ 
and a short, ten-week consultation period – 
betoken a political exigency to find some 
tangible good that might come from Brexit’.75 
While this raises the issue that the consultation 
may be overshadowed by political concerns and 
may fail to be objective, the consultation is 
nonetheless carried out in line with the standard 
model of government written consultations 
aiming to consolidate views of stakeholders, 
while also promoting wider discussion of the 
relevant issues.  
The Defra consultation will first seek to 
gather views on the potential for the UK to stop 
gene editing organisms from being subject to the 
same strict regulation as GMOs, as long as they 
could have been produced naturally or via 
traditional breeding methods.76 In this way, the 
UK’s legislation would be in line with the 
approach taken by an increasing number of 





74 Foote N. UK gene editing amendment withdrawn, 




29 March 2021. 
75 Mills P. The regulation of genetic technologies: 
time for dialogue. Nuffield Council on Bioethics 
2021. https://www.nuffieldbioethics.org/blog/the-
regulation-of-genetic-technologies accessed 29 
March 2021. 
76 Defra. The regulation of genetic technologies. Op 
cit. 
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countries, such as Australia and Japan.77 Indeed, 
several other European countries, as well as the 
European Commission’s own group of scientific 
advisors are of the same view that gene edited 
organisms should be regulated with a lighter 
touch.78 
Yet in addition to gene editing, the 
consultation also aims to be the start of a longer-
term project seeking to collect evidence and best 
practice on updating the UK’s approach to 
genetic modification.79 Consulting with key 
stakeholders, such as the food and farming 
sectors, academia, and environmental groups 
forms the beginning of a process that may, 
therefore, depending on the result, require new 
primary UK legislation to be drawn up, 
scrutinised and approved by Parliament.80 
 
II. Second part of Defra consultation 
The second half of the Defra consultation 
centres on the broader framework of GMOs.81 It 
is important to note that the consultation does not 
aim to put into place immediate changes, and 
instead seeks to gather information on how Defra 
can best reform its approach to new gene edited 
organisms in future.82 Moreover, it considers the 
effectiveness of current non-GM regulations that 
regulate GMOs in relation to specific sectors, 
such as in medicines, human food, farmed 
animals, crop plants.83 
However, there are valid concerns that the 
narrow focus of the consultation on the 
organisms per se demonstrates that product 





77 Defra. A public consultation on the regulation of 
genetic technologies. Op cit.: 5. 
78 Mills, op cit. 
79 Ibidem.  
80 Defra. The regulation of genetic technologies. Op 
cit.: 6. 
81 Ibidem.  
82 Idem: 7. 
83 Idem: 5.  
safety is the main factor driving the discussion.84 
Indeed, the consultation refers explicitly to 
factors such as ‘impacts on trade, consumer 
choice, [and] intellectual property’.85 Yet the 
Nuffield Council of Bioethics has pointed out 
that there are many other interdependent 
elements that are involved in the discussion on 
gene edited organisms, including animal health, 
nutrition, zoonotic disease, ecosystems, 
biodiversity, climate, rural livelihoods, supply 
chains, industry structure and food security.86 
Moreover, these general considerations will be 
relevant whether or not the biotechnologies in 
question produce organisms that develop as a 
result of ‘traditional’ breeding or not.87 
Therefore, it seems that the terms of the 
consultation may have been drawn up too 
narrowly and it is suggested that in evaluating 
the outcome, Defra should acknowledge any 
gaps in the responses received in relation to these 
broader considerations.   
 
III. Responses to Defra consultation 
So far, the responses to the Defra 
consultation so far have been split between the 
pro-biotech scientists and the anti-GM 
organisations. While the former have been 
accused of using the consultation as an 
opportunity to push for more lax regulation in 
applications of gene editing, the latter seem to 
have drawn up their responses against the 
background of negative public attitudes towards 
UK agricultural biotechnology.  
 
1. Responses against the deregulation of 
gene editing 
Indeed, the anti-GM NGOs have 
emphasised several issues with the consultation. 






85 Ibidem.  
86 Ibidem.  
87 Ibidem.  
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Foremost amongst them are the dangers, GM 
Freeze sees it, of moving from a product- to a 
process-based approach to the regulation of gene 
edited and gene modified organisms.88 As 
highlighted in their guide on responding to the 
consultation, ‘Any unexpected effects, such as 
new allergens or toxins, may go unnoticed. This 
is not safe or sensible’.89 Additionally, as GM 
Freeze has stated, in collaboration with Beyond 
GM, GM Watch, Logos Environmental and 
EcoNexus, another concern relates to how the 
consultation focuses on so-called ‘technofixes’ - 
to the exclusion of systemic change.90 As these 
anti-GMO NGOs explain, while they accept the 
consultation’s premise that the UK’s food system 
has to change, they argue that the changes 
needed involve the ‘widespread adoption of 
agroecological farming systems, a massive 
reduction in food waste, and food sovereignty, 
which gives people around the world control 
over their own food supply’.91 They contrast this 
with gene editing, which makes big promises to 
improve crop yields, tackle climate change, 
strengthen biodiversity, and improve the UK 
economy, but that rely on the assumption that 
complex social, political and economic issues 
stem from plant and animal breeding and that 
these can somehow be ‘fixed’ by ‘tweaking’ the 
genes of living organisms.92 These NGOs 
highlight that the agricultural problems the UK 





88 GM Freeze. GM Freeze response to Defra 
Consultation on the Regulation of Genetic 




Technologies.pdf accessed 29 March 2021. 
89 GM Freeze. GM Freeze advice on responding to 
the UK consultation on the deregulation of gene 
editing. Op cit.: 6. 
90 Ibidem. 
91 Ibidem.  
92 Ibidem.  
faces are more complex and deep-rooted than 
that, and that it would therefore be unwise to 
place too much hope on ‘short-term technofixes’ 
which only impede long-lasting systemic 
change.93 
Besides these concerns relating to human 
health and short-term agricultural fixes, other 
criticisms surrounding the consultation centre on 
animal welfare. Against the background of gene 
editing being perceived by some mainstream 
news outlets as ‘playing God’, some have 
pointed to the harm that may be caused to 
animals by the possible deregulation of gene 
editing. As Dr Julia Baines, Science Policy 
Manager at PETA, stated: 
'We have no business meddling with the 
lives of other animals, who don’t consent to 
our tampering with their genomes to 
increase their profitability. Pigs, cows, and 
chickens are intelligent, sensitive, social 
beings who have their own lives, feelings, 
and desires and don’t exist for humans to 
use....'Editing animals’ genes won't solve 
world hunger – as a global switch to vegan 
eating could – and it will lead to misery for 
animals’.94 
Similarly, Dr Penny Hawkins, head of the 
RSPCA's Animals in Science team, predicts that 
lowering oversight over gene editing would be a 
step backwards for animal welfare. 
'We have real concerns about gene 
editing and the animal welfare issues 
involved. The impact of these changes to the 





93 Ibidem.  
94 Pinkstone J. UK government is set to lift the ban on 
controversial gene editing in agriculture so crops and 
livestock can be engineered to boost yields and 
protect them against disease. Daily Mail 2021. 
https://www.dailymail.co.uk/sciencetech/article-
9368255/UK-government-set-lift-ban-controversial-
gene-editing-agriculture.html accessed 29 March 
2021. 
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genome is very unpredictable and there are 
so many unknowns about the long-term 
impacts of alterations to the animals' genetic 
material, so there is a real risk of welfare 
problems being passed down the 
generations. We are incredibly worried that 
the Government is considering relaxing the 
rules around these procedures and, 
shockingly, this would also see farm 
animals categorised with and only given the 
same level of consideration as farmed 
crops’.95 
In addition to this, and with respect to the 
role of regulations in providing essential 
safeguards to human and animal health, criticism 
has been raised regarding the potential loss of 
transparency and the removal of essential 
protections from the deregulation of gene 
editing.96 Accusations that the UK government is 
seeking to ‘obscure’ where food comes from and 
how it was produced are voiced alongside 
skepticism regarding the risk of new 
technologies being given ‘free rein’ within the 
food system.97 
Some scientists have also expressed 
caution in the deregulation of gene edited and 
gene modified organisms. In 2017 a statement 
published by the European Network of Scientists 
for Social and Environmental Responsibility 
(ENSSER) was signed by scientists worldwide. 
One of its recommendations was that, ‘due to our 
lack of knowledge and the possibility of 
unintended errors, the products of new genetic 
modification techniques should be strictly 
regulated as GMOs’.98 





95 Ibidem.  
96 GM Freeze. GM Freeze advice on responding to 
the UK consultation on the deregulation of gene 
editing. Op cit.: 6. 
97 Ibidem.  
98 European Network of Scientists for Social and 
Environmental Responsibility. ENSSER Statement 
2. Responses in favour of the deregulation 
of gene editing 
However, the pro-biotech lobbyists insist 
that gene editing could improve the agriculture 
and aquaculture system and could help feed a 
growing population. As the UK Environment 
Secretary, George Eustice, said:  
‘Gene editing has the ability to harness the 
genetic resources that mother nature has 
provided, in order to tackle the challenges of 
our age. This includes breeding crops that 
perform better, reducing costs to farmers 
and impacts on the environment, and 
helping us all adapt to the challenges of 
climate change. Its potential was blocked by 
a European Court of Justice ruling in 2018, 
which is flawed and stifling to scientific 
progress. Now that we have left the EU, we 
are free to make coherent policy decisions 
based on science and evidence. That begins 
with this consultation’.99 
Farmers and scientists tend to be in favour of 
removing these so-called blocks to progress. As 
Tom Bradshaw, vice president of the National 
Farmers Union, argued: 'Gene editing has the 
potential to offer huge benefits to UK farming 
and the environment. It could help us address 
pest and disease pressures on our crops and 
livestock, increasing our resilience in the event 
of extreme weather events’.100 
Others in the agricultural sector agree. The 
Agricultural Industries Confederation (AIC) has 
responded warmly to the Defra consultation. 





on New Genetic Modification Techniques 2017. 
https://ensser.org/publications/ngmt-statement 
accessed 29 March 2021. 
99 Byrne J. UK feed and pig industries welcome UK 
consultation on gene editing. Feed Navigator 2021. 
https://www.feednavigator.com/Article/2021/01/07/U
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2021. 
100 Pinkstone, op cit. 
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Robert Sheasby, CEO of the AIC, repesenting 
the voices of the UK feed and agri-supply sector, 
announced that:  
‘The AIC warmly welcomes the launch of 
this government consultation on gene 
editing in crops and livestock. We have long 
sought to support sustainable modern 
commercial agriculture in the UK, and this 
is the opportunity for our members to put 
forward their views on this development. 
We would encourage the industry at large to 
respond’.101 
Similarly, a number of UK governmental 
departments have responded positively to the 
possibility that the consultation could lead to a 
change in legislation. Professor Robin May, 
chief scientific officer of the UK’s Food 
Standards Agency (FSA), welcomed the 
consultation, stating that: 
‘The UK prides itself in having the very 
highest standards of food safety, and there 
are strict controls on GM crops, seeds and 
food which the FSA will continue to apply 
moving forward. As with all novel foods, 
GE foods will only be permitted to be 
marketed if they are judged to not present a 
risk to health, not to mislead consumers, and 
not have lower nutritional value than 
existing equivalent foods. We will continue 
to put the consumer first and be transparent 
and open in our decision-making. Any 
possible change would be based on an 
appropriate risk assessment that looks at the 
best available science’.102 
Indeed, such changes have been 
increasingly anticipated in light of the 2020 
Nobel Prize in Chemistry being awarded to 
Emmanuelle Charpentier and Jennifer A. 
Doudna ‘for the development of a method for 
genome editing’ in the form of CRISPR-Cas9 





101 Ibidem.   
102 Byrne, op cit. 
gene editing.103 In this light, Sir David 
Baulcombe, professor of botany in the 
Department of Plant Sciences at the University 
of Cambridge, pointed out that the 
overwhelming view of public sector scientists is 
that these Nobel prize winning methods for gene 
editing can lead to better availability of crops 
and livestock as part of a sustainable and 
profitable agricultural system.104 
One such public sector scientists point to 
the potential for improvement of animal welfare 
following the lifting of restrictions on gene 
editing. As Prof Mick Watson, Personal Chair of 
Bioinformatics and Computational Biology, 
Roslin Institute, University of Edinburgh, stated:  
‘Not only does the information in their 
genes control how animals grow, it also 
provides routes for pathogens such as 
viruses to enter animal cells and cause 
disease.  Scientists at The Roslin Institute, 
and elsewhere in the world, have identified 
genes, or loci, within animal genomes that 
confer both susceptibility and resistance to a 
range of diseases, and we have 
demonstrated the power of gene editing by 
creating pigs that are resistant to Porcine 
Reproductive and Respiratory Syndrome, a 
devastating viral disease. 
As well as improving animals’ ability to 
respond to disease, gene editing could also 
be used to create fitter, healthier animals 
with higher standards of animal welfare.  I 
welcome this initiative from Defra which 





103 Ryan Cross, ’CRISPR genome editing gets 2020 
Nobel Prize in Chemistry’ (C&EN, 9 October 2020) 
https://cen.acs.org/biological-chemistry/gene-
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accessed 29 March 2021. 
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could place cutting-edge technology at the 
heart of UK livestock improvement’.105 
The diverse range of views that have been 
put forward during this consultation will be 
considered by Defra and published in a few 
months' time. At the moment, since Defra itself 
seems to be staunchly in favour of a relaxation of 
the rules on gene edited organisms within the 
agriculture and aquaculture system, these 
scientists’ and farmers’ positive responses to the 
consultation seem to strengthen Defra’s resolve 
to push through new legislation.  
 
IV. Suggestions for Defra consultation results 
While the outcome seems set to provide 
more support to a new regulatory framework in 
the UK, perhaps along the lines of the US or 
Canada’s less restrictive approach to biotech, it 
is still important that several key considerations 
aiming to balance competing interests are used in 
assessing the outcome. Some proposed 
considerations include:  
1. All forms of gene editing should be subject 
to robust, but possibly differing levels of, 
regulation and risk assessments. 
2. The consultation should operate against the 
background of a greater recognition of the 
whole host of other approaches to ensuring 
a sustainable and healthy food system, in-
cluding organic and other agroecological 
farming. 
3. Whether or not GM assessments are re-
tained, it may be useful to extend the as-
sessments to include social, ethical and 
values-based criteria. 
4. Genetic engineering legislation should take 
into account a consideration of the alterna-





105 Science Media Centre. Expert reaction to Defra 
consultation on gene editing. 2021. 
https://www.sciencemediacentre.org/expert-reaction-
to-defra-consultation-on-gene-editing/ accessed 29 
March 2021. 
tives, including traditional alternatives, and 
require a detailed and independently as-
sessed. justification of the social and envi-
ronmental need for the proposed new or-
ganism 
5. Long-term safety assessments should be 
carried out that consider all unintended ef-
fects. 
6. Post-release monitoring of gene-edited or 
modified organisms should be prioritised. 
7. Consumer labeling should be as clear as 
possible so as to support and educate con-
sumer choice. 
8. Should gene edited food be made available 
on the market, public awareness of the dif-
ference between gene edited and modified 
food products could be raised through in-
formation campaigns to empower consum-
ers to make their own decisions about the 
food they purchase and consume. 
Besides all these suggestions, it is 
important that the developments in legislation on 
GM and GE products across jurisdictions around 
the world continue to be monitored. While a 
short summary of the legal framework in several 
countries has been provided in previous sections, 
the growing acceptance of governments of the 
need to foster scientific advancements in GM 
and GE means that there may soon be more 
countries - and not just the UK - that will look to 
the US and Canada as prime examples of less 
restrictive regulatory systems. 
 
D. Conclusion 
Ultimately, any consideration of changes 
to UK legislation that allow gene edited 
agricultural and aquacultural products to enter 
into the market and to be further developed by 
scientists must operate within a broader 
framework of the challenges facing the UK food 
and farming system. Regardless of the outcome 
of the Defra consultation, its role in raising 
awareness of the relevance of gene editing is 
hugely important. Informed debate on the 
complex societal, ethical, animal, economic, and 
environmental issues associated with gene edited 
products will help to shape future national policy 
as a new generation of biotechnologies is 
developed and will help to direct the 
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